Biotech · Private company
SynteractHCR
Track this companyFree. Adds SynteractHCR to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerPHASE3 · COMPLETED · started Jan 26, 2018ClinicalTrials.gov NCT03180307 · fetched Nov 12, 2026
- A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusPHASE3 · COMPLETED · started Jun 28, 2017ClinicalTrials.gov NCT03216226 · fetched Nov 12, 2026
- A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPLPHASE1 · COMPLETED · started Jan 16, 2017ClinicalTrials.gov NCT03931993 · fetched Nov 12, 2026
- Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental SubjectsPHASE2 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02594254 · fetched Nov 12, 2026
- X-82 to Treat Age-related Macular DegenerationPHASE2 · TERMINATED · started Mar 16, 2015ClinicalTrials.gov NCT02348359 · fetched Nov 12, 2026
- Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian CancerPHASE2 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT02317705 · fetched Nov 12, 2026